MX2015013092A - Modificación y nuevas composiciones de proteínas secretoglobinas de humano. - Google Patents
Modificación y nuevas composiciones de proteínas secretoglobinas de humano.Info
- Publication number
- MX2015013092A MX2015013092A MX2015013092A MX2015013092A MX2015013092A MX 2015013092 A MX2015013092 A MX 2015013092A MX 2015013092 A MX2015013092 A MX 2015013092A MX 2015013092 A MX2015013092 A MX 2015013092A MX 2015013092 A MX2015013092 A MX 2015013092A
- Authority
- MX
- Mexico
- Prior art keywords
- protein
- isoforms
- preparations
- novel
- novel compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000011274 Secretoglobin Human genes 0.000 title 1
- 108050001520 Secretoglobin Proteins 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 4
- 108010029485 Protein Isoforms Proteins 0.000 abstract 4
- 238000002360 preparation method Methods 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 108090000203 Uteroglobin Proteins 0.000 abstract 2
- 102100031083 Uteroglobin Human genes 0.000 abstract 2
- 101000777301 Homo sapiens Uteroglobin Proteins 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000055576 human SCGB1A1 Human genes 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007845 reactive nitrogen species Substances 0.000 abstract 1
- 239000003642 reactive oxygen metabolite Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/843,773 US9394349B2 (en) | 2013-03-15 | 2013-03-15 | Modification and compositions of human secretoglobin proteins |
| PCT/US2014/030117 WO2014145368A2 (en) | 2013-03-15 | 2014-03-17 | Modification and novel compositions of human secretoglobin proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015013092A true MX2015013092A (es) | 2016-06-02 |
Family
ID=51530119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015013092A MX2015013092A (es) | 2013-03-15 | 2014-03-17 | Modificación y nuevas composiciones de proteínas secretoglobinas de humano. |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9394349B2 (enExample) |
| EP (2) | EP2968449A4 (enExample) |
| JP (2) | JP6670987B2 (enExample) |
| KR (1) | KR20160030076A (enExample) |
| CN (1) | CN105744946A (enExample) |
| AU (1) | AU2014233127A1 (enExample) |
| BR (1) | BR112015021266A2 (enExample) |
| CA (1) | CA2907439A1 (enExample) |
| IL (1) | IL241417A0 (enExample) |
| MX (1) | MX2015013092A (enExample) |
| RU (1) | RU2015144360A (enExample) |
| SG (1) | SG11201507277YA (enExample) |
| WO (1) | WO2014145368A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12162914B2 (en) | 2013-03-15 | 2024-12-10 | Apc Research Assets Llc | Modification and compositions of human secretoglobin proteins |
| US9394349B2 (en) * | 2013-03-15 | 2016-07-19 | Therabron Therapeutics, Inc. | Modification and compositions of human secretoglobin proteins |
| AU2015369776A1 (en) * | 2014-12-22 | 2017-06-15 | The Regents Of The University Of California | Compositions and methods for generating antigens, antibodies, and immunotherapeutic compositions and methods |
| US20180325931A1 (en) | 2017-01-21 | 2018-11-15 | Ningbo Zhiming Biotechnology Co., Ltd. | Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome |
| US11690893B2 (en) | 2018-11-30 | 2023-07-04 | Apc Research Assets Llc | Compositions and methods of use for secretoglobins to protect the glycocalyx via interactions with heparan sulfate proteoglycan proteins |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1006919A3 (nl) * | 1993-03-15 | 1995-01-24 | Ley Marc Jozef Philemon De | Farmaceutisch preparaat op basis van clara celeiwit cc10, en het gebruik daarvan als geneesmiddel en diagnosticum. |
| US20040047857A1 (en) * | 1997-05-28 | 2004-03-11 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20030008816A1 (en) | 1997-05-28 | 2003-01-09 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20060281681A1 (en) | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| WO2000009741A1 (en) | 1998-08-13 | 2000-02-24 | The Trustees Of The University Of Pennsylvania | Method of identifying proteins |
| US6953666B1 (en) | 1998-11-06 | 2005-10-11 | Emory University | Biomarkers for oxidative stress |
| WO2004101824A1 (ja) | 2003-05-14 | 2004-11-25 | Shionogi & Co., Ltd. | 慢性閉塞性肺疾患の検出方法 |
| AU2004254600A1 (en) | 2003-06-26 | 2005-01-13 | Lifesensors, Inc. | Methods and compositions for enhanced protein expression and purification |
| CN1580261A (zh) * | 2003-08-06 | 2005-02-16 | 上海富纯中南生物技术有限公司 | Cc10蛋白的制备及应用 |
| WO2005048993A2 (en) | 2003-11-14 | 2005-06-02 | Alza Corporation | Minimization of drug oxidation in drug irradiated excipients formulations |
| US20060275794A1 (en) | 2005-03-07 | 2006-12-07 | Invitrogen Corporation | Collections of matched biological reagents and methods for identifying matched reagents |
| WO2008039941A2 (en) | 2006-09-27 | 2008-04-03 | The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services | Scgb3a2 as a growth factor and anti-apoptotic agent |
| US20090004684A1 (en) | 2007-05-23 | 2009-01-01 | Claudia Susanne Maier | Compositions and Methods for Detection and Quantification of Protein Oxidation |
| KR101597391B1 (ko) * | 2009-10-15 | 2016-02-24 | 클라라산스, 인크. | 인플루엔자 치료용 재조합 사람 ｃｃ10 단백질 |
| US9394349B2 (en) * | 2013-03-15 | 2016-07-19 | Therabron Therapeutics, Inc. | Modification and compositions of human secretoglobin proteins |
-
2013
- 2013-03-15 US US13/843,773 patent/US9394349B2/en active Active
-
2014
- 2014-03-17 RU RU2015144360A patent/RU2015144360A/ru unknown
- 2014-03-17 EP EP14765106.1A patent/EP2968449A4/en not_active Withdrawn
- 2014-03-17 MX MX2015013092A patent/MX2015013092A/es unknown
- 2014-03-17 CN CN201480015618.3A patent/CN105744946A/zh active Pending
- 2014-03-17 KR KR1020157029582A patent/KR20160030076A/ko not_active Ceased
- 2014-03-17 SG SG11201507277YA patent/SG11201507277YA/en unknown
- 2014-03-17 WO PCT/US2014/030117 patent/WO2014145368A2/en not_active Ceased
- 2014-03-17 AU AU2014233127A patent/AU2014233127A1/en not_active Abandoned
- 2014-03-17 CA CA2907439A patent/CA2907439A1/en not_active Abandoned
- 2014-03-17 EP EP18167516.6A patent/EP3403666A1/en not_active Withdrawn
- 2014-03-17 BR BR112015021266A patent/BR112015021266A2/pt not_active IP Right Cessation
- 2014-03-17 JP JP2016503333A patent/JP6670987B2/ja active Active
-
2015
- 2015-09-09 IL IL241417A patent/IL241417A0/en unknown
-
2016
- 2016-07-17 US US15/212,277 patent/US10294285B2/en active Active
-
2019
- 2019-05-20 US US16/416,268 patent/US10676513B2/en active Active
- 2019-12-02 JP JP2019218277A patent/JP2020055833A/ja active Pending
-
2020
- 2020-06-09 US US16/896,213 patent/US20200325190A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014233127A1 (en) | 2015-09-24 |
| US20140275477A1 (en) | 2014-09-18 |
| JP2020055833A (ja) | 2020-04-09 |
| RU2015144360A (ru) | 2017-04-24 |
| JP6670987B2 (ja) | 2020-03-25 |
| WO2014145368A2 (en) | 2014-09-18 |
| CA2907439A1 (en) | 2014-09-18 |
| EP2968449A2 (en) | 2016-01-20 |
| US10294285B2 (en) | 2019-05-21 |
| US9394349B2 (en) | 2016-07-19 |
| BR112015021266A2 (pt) | 2017-10-10 |
| SG11201507277YA (en) | 2015-10-29 |
| JP2016515532A (ja) | 2016-05-30 |
| KR20160030076A (ko) | 2016-03-16 |
| US10676513B2 (en) | 2020-06-09 |
| WO2014145368A3 (en) | 2014-11-27 |
| EP3403666A1 (en) | 2018-11-21 |
| US20200325190A1 (en) | 2020-10-15 |
| US20160362462A1 (en) | 2016-12-15 |
| CN105744946A (zh) | 2016-07-06 |
| US20190337999A1 (en) | 2019-11-07 |
| EP2968449A4 (en) | 2017-03-22 |
| IL241417A0 (en) | 2015-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015013092A (es) | Modificación y nuevas composiciones de proteínas secretoglobinas de humano. | |
| MX2021010528A (es) | Metodos y composiciones para el tratamiento de las ulceras. | |
| MX374477B (es) | Composicion y productos que comprenden celulas senescentes para su uso en la regeneracion de tejidos | |
| PH12018500641A1 (en) | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
| TN2012000372A1 (en) | Fibronectin based scaffold domain proteins that bind il-23 | |
| EA201500261A1 (ru) | Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 158p1d7 | |
| MX2025010350A (es) | Composiciones y metodos para aumentar la hemoglobina fetal y tratar la anemia de celulas falciformes | |
| GB2544270A8 (en) | Nucleic acids, peptides and methods | |
| MX2011008094A (es) | Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos. | |
| EA201491470A1 (ru) | Композиции фактора viii и способы получения и использования подобных | |
| ECSP12012211A (es) | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) | |
| BR112015022934A8 (pt) | esteróides neuroativos, composições e usos destes | |
| MX2016005101A (es) | Factor de crecimiento de fibroblastos (fgf) 1 mutado y procedimientos de uso. | |
| MX336489B (es) | Hormona foliculo estimulante humana recombinante composicion farmaceutica que la comprende y uso de la misma. | |
| MX2017014730A (es) | Muteinas de lipocalina 2 humana con afinidad por glipicano-3 (gpc3). | |
| TN2013000427A1 (en) | Modified acid alpha glucosidase with accelerated processing | |
| BR112013003823A2 (pt) | conjugados de peptídeo terapêutico-políemro, partículas, composições, e métodos relacionados | |
| MA40057A (fr) | Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants | |
| DE602005026724D1 (de) | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz-kreislauf-leiden | |
| MX379241B (es) | ANTICUERPOS DE UNIÓN A PROTOFIBRILLAS BETA AMILOIDE (Aß) MEJORADOS. | |
| WO2015067755A3 (en) | Novel methods and antibodies for treating coagulapathy | |
| NZ715203A (en) | Heparan sulphates | |
| MX2014004953A (es) | Ligadores basados en tirosina para la conexion desprendible de peptidos. | |
| BR112015019568A2 (pt) | Peptídeo isolado, composição compreendendo o mesmo e uso do mesmo | |
| BR112013009660A2 (pt) | proteína de fusão com fator de atividade ix |